Takashi Kuroha
Overview
Explore the profile of Takashi Kuroha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
352
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuroha T, Furukawa T, Yoshikawa S, Kaihatsu A, Nemoto H, Usuda H, et al.
Int J Hematol
. 2025 Jan;
121(3):421-426.
PMID: 39756003
Sinusoidal obstruction syndrome (SOS), also known as hepatic veno-occlusive disease (VOD), is a life-threatening complication of hematopoietic stem cell transplantation. In severe cases, SOS/VOD progresses to multiple organ failure with...
2.
Sugita J, Kuroha T, Ishikawa J, Eto T, Fukushima K, Yokota I, et al.
Bone Marrow Transplant
. 2023 Dec;
59(3):344-349.
PMID: 38114645
Posttransplant cyclophosphamide (PTCy)-based graft-versus-host disease (GVHD) prophylaxis has been increasingly used in HLA-haploidentical transplantation and recent studies also demonstrated the efficacy of PTCy in HLA-matched transplantation. We conducted a prospective...
3.
Sugita J, Kamimura T, Ishikawa T, Ota S, Eto T, Kuroha T, et al.
Bone Marrow Transplant
. 2020 Sep;
56(3):596-604.
PMID: 32973350
Posttransplant cyclophosphamide (PTCy:100 mg/kg) has been increasingly used in allogeneic hematopoietic stem cell transplantation, however, few studies compared different doses of PTCy. We conducted two consecutive prospective multicenter phase II...
4.
Saeki T, Kuroha T, Sato Y, Tamura M, Iguchi A, Ito T, et al.
BMC Nephrol
. 2019 Dec;
20(1):464.
PMID: 31842799
Background: Although most cases of tubulointerstitial nephritis in paraproteinemia are monoclonal light chain deposition-mediated, interstitial nephritis as neoplastic interstitial cell infiltration has rarely been described. On the other hand, lympho-plasma-cell-rich...
5.
Fuse K, Uemura S, Tamura S, Suwabe T, Katagiri T, Tanaka T, et al.
Cancer Med
. 2019 Jul;
8(11):5058-5067.
PMID: 31305031
Although allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative therapy for high-risk acute leukemia (AL), some patients still relapse. Since patients simultaneously have many prognostic factors, difficulties are associated...
6.
Shibasaki Y, Suwabe T, Katagiri T, Tanaka T, Ushiki T, Fuse K, et al.
Int J Hematol
. 2018 May;
108(3):282-289.
PMID: 29744806
The Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) is a widely used tool for pre-transplant risk assessment. Allogeneic hematopoietic cell transplantation (HCT) is performed on patients with diverse backgrounds, highlighting the...
7.
Shibasaki Y, Suwabe T, Katagiri T, Tanaka T, Kobayashi H, Fuse K, et al.
Clin Transplant
. 2017 Sep;
31(11).
PMID: 28871665
Evaluation methods, such as scoring systems for predicting complications in advance, are necessary for determining the adaptation of allogeneic hematopoietic cell transplantation (HCT) and selecting appropriate conditioning regimens. The Hematopoietic...
8.
The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma
Hashimoto S, Kuroha T, Yano T, Sato N, Furukawa T
Intern Med
. 2016 Oct;
55(20):3025-3028.
PMID: 27746443
Five cases were treated by adding daily low-dose thalidomide (50 mg) to bortezomib and dexamethasone therapy for refractory multiple myeloma. This therapy was effective in four cases, with an improvement...
9.
Shibasaki Y, Seki Y, Tanaka T, Miyakoshi S, Fuse K, Kozakai T, et al.
Leuk Res
. 2015 Apr;
39(6):667-71.
PMID: 25890432
We focused on the level of reduction of Wilms' tumor gene 1 (WT1) mRNA in bone marrow as minimal residual disease during chemotherapies in adult acute myeloid leukemia (AML) patients....
10.
Yagisawa K, Okazuka K, Toba K, Urushiyama M, Kuroha T, Izumi N, et al.
Int J Hematol
. 2012 Feb;
95(4):420-7.
PMID: 22362009
Myelodysplastic syndrome (MDS) is relatively common in the elderly, and aging of populations is progressing in developed nations, notably so in Japan. The major age group in Japan and Sado...